Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy
BBA Clinical · 2015-06 · 3 · 168-174
DOI: 10.1016/j.bbacli.2015.02.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift BBA Clinical, 2015-06. Verfasst von Tadanobu Nagaya und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Shinshu University School of Medicine, Matsumoto, Japan. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND AND AIM: It is recognized that nonalcoholic fatty liver disease (NAFLD), including nonalcoholic steatohepatitis (NASH), may develop after pancreaticoduodenectomy (PD). However, the mechanism of NASH development remains unclear. This study aimed to examine the changes in gene expression associated with NASH occurrence following PD. METHODS: The expression of genes related to fatty acid/triglyceride (FA/TG) metabolism and inflammatory signaling was examined using liver samples obtained from 7 post-PD NASH patients and compared with 6 healthy individuals and 32 conventional NASH patients. RESULTS: The livers of post-PD NASH patients demonstrated significant up-regulation of the genes encoding CD36, FA-binding proteins 1 and 4, acetyl-coenzyme A carboxylase α, diacylglycerol acyltransferase 2, and peroxisome proliferator-activated receptor (PPAR) γ compared with normal and conventional NASH livers. Although serum apolipoprotein B (ApoB) and TG were decreased in post-PD NASH patients, the mRNAs of ApoB and microsomal TG transfer protein were robustly increased, indicating impaired TG export from the liver as very-low-density lipoprotein (VLDL). Additionally, elevated mRNA levels of myeloid differentiation primary response 88 and superoxide dismutases in post-PD NASH livers suggested significant activation of innate immune response and augmentation of oxidative stress generation. CONCLUSIONS: Enhanced FA uptake into hepatocytes and lipogenesis, up-regulation of PPARγ, and disruption of VLDL excretion into the circulation are possible mechanisms of steatogenesis after PD. GENERAL SIGNIFICANCE: These results provide a basis for understanding the pathogenesis of NAFLD/NASH following PD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Shinshu University School of Medicine, Matsumoto, Japan.
- Department of Gastroenterology, Shinshu University School of Medicine, Matsumoto, Japan ; Department of Metabolic Regulation, Shinshu University Graduate School of Medicine, Matsumoto, Japan.
- Digestive Disease Center, Showa Inan General Hospital, Komagane, Japan.
- Department of Gastroenterology, Iida Municipal Hospital, Iida, Japan.
- Department of Laboratory Medicine, Shinshu University Hospital, Matsumoto, Japan.
- Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States.
Zitieren
APA
Nagaya, T., Tanaka, N., Kimura, T., Kitabatake, H., Fujimori, N., Komatsu, M., Horiuchi, A., Yamaura, T., Umemura, T., Sano, K., Gonzalez, F. J., Aoyama, T., & Tanaka, E. (2015). Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy. BBA Clinical, 3, 168-174. https://doi.org/10.1016/j.bbacli.2015.02.001
Vancouver
Nagaya T, Tanaka N, Kimura T, Kitabatake H, Fujimori N, Komatsu M, et al. Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy. BBA Clinical. 2015;3:168-174. doi:10.1016/j.bbacli.2015.02.001
BibTeX
@article{Nagaya2015,
author = {Nagaya, Tadanobu and Tanaka, Naoki and Kimura, Takefumi and Kitabatake, Hiroyuki and Fujimori, Naoyuki and Komatsu, Michiharu and Horiuchi, Akira and Yamaura, Takahiro and Umemura, Takeji and Sano, Kenji and Gonzalez, Frank J and Aoyama, Toshifumi and Tanaka, Eiji},
title = {Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy},
journal = {BBA Clinical},
year = {2015},
volume = {3},
pages = {168--174},
doi = {10.1016/j.bbacli.2015.02.001}
}
EUVIMED